BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19860247)

  • 1. [Mechanism behind streptococcus toxic shock-like syndrome onset--immune evasion and bacterial properties].
    Ikebe T; Ato M; Kobayashi K; Watanabe H
    Kansenshogaku Zasshi; 2009 Sep; 83(5):485-9. PubMed ID: 19860247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator.
    Ato M; Ikebe T; Kawabata H; Takemori T; Watanabe H
    PLoS One; 2008; 3(10):e3455. PubMed ID: 18941623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
    Reglinski M; Sriskandan S
    Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.
    Ikebe T; Ato M; Matsumura T; Hasegawa H; Sata T; Kobayashi K; Watanabe H
    PLoS Pathog; 2010 Apr; 6(4):e1000832. PubMed ID: 20368967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
    Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of spontaneous fabT mutations to a streptococcal toxic shock syndrome to non-streptococcal toxic shock syndrome transition in the novel-type Streptococcus pyogenes isolates that lost a salRK.
    Tatsuno I; Okada R; Matsumoto M; Hata N; Matsui H; Zhang Y; Isaka M; Hasegawa T
    APMIS; 2016 May; 124(5):414-24. PubMed ID: 26861052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome.
    Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome.
    Krause R
    FEMS Immunol Med Microbiol; 1997 Aug; 18(4):227-32. PubMed ID: 9348157
    [No Abstract]   [Full Text] [Related]  

  • 9. [Properties of extracellular products produced by group A streptococci isolated from patient with streptococcal toxic shock syndrome].
    Suzuki J; Yoshihara E; Kobayashi S
    Kansenshogaku Zasshi; 1997 Mar; 71(3):273-8. PubMed ID: 9128015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.
    Shiseki M; Miwa K; Nemoto Y; Kato H; Suzuki J; Sekiya K; Murai T; Kikuchi T; Yamashita N; Totsuka K; Ooe K; Shimizu Y; Uchiyama T
    Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock.
    Llewelyn M
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S445-8. PubMed ID: 16237645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome.
    Matsumura T; Nishiyama A; Aiko M; Ainai A; Ikebe T; Chiba J; Ato M; Takahashi Y
    BMC Res Notes; 2020 Sep; 13(1):419. PubMed ID: 32891180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-chain variable fragment (scFv) targeting streptolysin O controls group A Streptococcus infection.
    Aikawa C; Kawashima K; Fukuzaki C; Nakakido M; Murase K; Nozawa T; Tsumoto K; Nakagawa I
    Biochem Biophys Res Commun; 2021 Aug; 566():177-183. PubMed ID: 34129965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome].
    Suzuki J; Matsubuchi S; Yoshihara E; Kobayashi S; Okamura K; Okuda T; Okazaki M; Furuya N; Uchimura H; Tokunaga T; Shimazaki S
    Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
    Eriksson BK; Andersson J; Holm SE; Norgren M
    J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous mutations in Streptococcus pyogenes isolates from streptococcal toxic shock syndrome patients play roles in virulence.
    Ikebe T; Matsumura T; Nihonmatsu H; Ohya H; Okuno R; Mitsui C; Kawahara R; Kameyama M; Sasaki M; Shimada N; Ato M; Ohnishi M
    Sci Rep; 2016 Jun; 6():28761. PubMed ID: 27349341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
    Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
    Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of streptococcal toxic shock syndrome caused by rapidly progressive group A hemolytic streptococcal infection during postoperative chemotherapy for cervical cancer.
    Nogami Y; Tsuji K; Banno K; Umene K; Katakura S; Kisu I; Tominaga E; Aoki D
    J Obstet Gynaecol Res; 2014 Jan; 40(1):250-4. PubMed ID: 23937219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcal toxic shock syndrome - a life-threatening condition caused by various streptococcal species.
    Bartoš H; Fabianová L; Dlouhý P
    Epidemiol Mikrobiol Imunol; 2018; 67(2):82-86. PubMed ID: 30126285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.